Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (221-230 of 359) with videos related to

Pageof 36
Sort By:
Nature Communications|December 5, 2018
Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacyPatrícia M R Pereira, Sai Kiran Sharma, Lukas M Carter, et al.
International Journal of Molecular Sciences|February 27, 2020
Manipulating the In Vivo Behaviour of <sup>68</sup>Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood ClearanceCinzia Imberti, Pierre Adumeau, Julia E Blower, et al.
Nuclear Medicine and Biology|May 26, 2019
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticalsSai Kiran Sharma, Serge K Lyashchenko, Hijin A Park, et al.
Pharmaceutical Research|December 11, 2012
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancerDiane S Abou, Daniel L J Thorek, Nicholas N Ramos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2019
An <sup>89</sup>Zr-HDL PET Tracer Monitors Response to a CSF1R InhibitorChristian A Mason, Susanne Kossatz, Lukas M Carter, et al.
Nuclear Medicine and Biology|July 2, 2003
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDGAtsushi Obata, Mitsuyoshi Yoshimoto, Shingo Kasamatsu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PETMichael G Doran, Philip A Watson, Sarah M Cheal, et al.
Macromolecular Rapid Communications|April 7, 2020
pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [<sup>18</sup> F]FluoromisonidazoleJeroen A C M Goos, Maria Davydova, Nigel Lengkeek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
PARaDIM: A PHITS-Based Monte Carlo Tool for Internal Dosimetry with Tetrahedral Mesh Computational PhantomsLukas M Carter, Troy M Crawford, Tatsuhiko Sato, et al.
Pageof 36

Showing results (221-230 of 359) with videos related to

Sort By:
Pageof 36
Nature Communications|December 5, 2018
Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacyPatrícia M R Pereira, Sai Kiran Sharma, Lukas M Carter, et al.
International Journal of Molecular Sciences|February 27, 2020
Manipulating the In Vivo Behaviour of <sup>68</sup>Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood ClearanceCinzia Imberti, Pierre Adumeau, Julia E Blower, et al.
Nuclear Medicine and Biology|May 26, 2019
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticalsSai Kiran Sharma, Serge K Lyashchenko, Hijin A Park, et al.
Pharmaceutical Research|December 11, 2012
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancerDiane S Abou, Daniel L J Thorek, Nicholas N Ramos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2019
An <sup>89</sup>Zr-HDL PET Tracer Monitors Response to a CSF1R InhibitorChristian A Mason, Susanne Kossatz, Lukas M Carter, et al.
Nuclear Medicine and Biology|July 2, 2003
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDGAtsushi Obata, Mitsuyoshi Yoshimoto, Shingo Kasamatsu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PETMichael G Doran, Philip A Watson, Sarah M Cheal, et al.
Macromolecular Rapid Communications|April 7, 2020
pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [<sup>18</sup> F]FluoromisonidazoleJeroen A C M Goos, Maria Davydova, Nigel Lengkeek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
PARaDIM: A PHITS-Based Monte Carlo Tool for Internal Dosimetry with Tetrahedral Mesh Computational PhantomsLukas M Carter, Troy M Crawford, Tatsuhiko Sato, et al.
Pageof 36